Loading clinical trials...
Loading clinical trials...
Influence of Co-diagnosis of Chronic Fatigue Syndrome in Patients With Fibromyalgia on Physical Activity, Quality of Life and Immunoneuroendocrine Response.
The purpose of this study is to evaluate differences in neuroimmunoendocrine response and quality of live in patients diagnosed with Fibromyalgia, with or without a co-diagnosis of Chronic Fatigue Syndrome.
The limited literature published in concordant relation affects the chronic fatigue syndrome comorbidity in the daily life of fibromyalgia patients leads us to design this study with the main objective of evaluating differences in the quality of life associated with pain and stress, mainly in relation to levels of physical activity, sedentary lifestyle and sleep in patients diagnosed with fibromyalgia, with or without a parallel co-diagnosis of chronic fatigue syndrome.
Age
40 - 65 years
Sex
FEMALE
Healthy Volunteers
Yes
University of Extremadura
Badajoz, Spain
Start Date
June 9, 2021
Primary Completion Date
June 22, 2021
Completion Date
November 16, 2024
Last Updated
May 11, 2023
140
ESTIMATED participants
Subjective quality of live
BEHAVIORAL
Blood extraction
PROCEDURE
Accelerometry
BEHAVIORAL
Synbiotic complement
DIETARY_SUPPLEMENT
Lead Sponsor
University of Extremadura
NCT05901259
NCT04542161
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions